Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage

Ann Rheum Dis. 2021 Jul;80(7):823-824. doi: 10.1136/annrheumdis-2021-220443. Epub 2021 May 14.
No abstract available

Keywords: ankylosing; arthritis; experimental; inflammation; spondylitis.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Inflammation
  • Osteogenesis
  • Spondylarthritis* / drug therapy
  • Spondylitis, Ankylosing*
  • Tenascin

Substances

  • Tenascin